This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: The Innovations of Nicolas J Skelton
Introduction
Nicolas J Skelton is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of biotechnology, particularly in the development of peptides that interact with insulin-like growth factors.
Latest Patents
Skelton holds a patent for "Insulin-like growth factor agonist molecules." This patent describes peptides that inhibit the interaction of an IGF with its binding proteins, while not affecting the human IGF receptor. These IGF agonist peptides are designed to increase serum and tissue levels of active IGFs in mammals. He has 1 patent to his name.
Career Highlights
Nicolas J Skelton is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Genentech has allowed him to explore and develop groundbreaking therapies that have the potential to improve health outcomes.
Collaborations
Throughout his career, Skelton has collaborated with esteemed colleagues, including Yvonne Man-Yee Chen and Ross Graham Clark. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
Nicolas J Skelton's contributions to biotechnology, particularly through his patented innovations, highlight his role as a significant figure in the field. His work continues to influence advancements in medical science and therapy development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile